{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/255960287"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Treatment of the metabolic syndrome with tocotrienols could then improve the different aspects of metabolic syndrome including obesity, insulin resistance and cardiovascular disease, as an alternative to treating each risk factor with a separate intervention with the increased risks of polypharmacy [23]." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "mdpi.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/274667995"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/255960287"] } } }
